AXIC-A aXichem AB (publ)

0.1619USD1.645 SEK · STO-1.20%Mkt Cap: 10.97M USDP/E: —

aXichem AB (publ), a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applicatio…

Key Statistics

Company
Market Cap10.97M USD
Enterprise Value10.74M USD
Revenue (TTM)1.60M USD
Gross Profit893.84K USD
Net Income (TTM)-1.74M USD
Revenue/Share0.03 USD
Last Price0.1619 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountrySE
SectorBasic Materials
IndustrySpecialty Chemicals
ISINSE0005250719
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.61
EV/Revenue6.71
P/S6.85
P/B2.02
EPS (TTM)-0.02 USD
EPS (Forward)—
52W Range
0.111718% of range0.3937
52W High0.3937 USD
52W Low0.1117 USD
Profitability
Gross Margin49.23%
Oper. Margin-94.23%
EBITDA Margin-77.94%
Profit Margin-95.59%
ROE-33.36%
ROA-28.86%
ROIC-32.08%
ROCE-33.08%
Growth
Revenue Growth-39.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.12M USD
CapEx (TTM)458.19K USD
FCF Margin-44.02%
FCF Yield-6.43%
Net Debt-224.22K USD
Net Debt/EBITDA0.18
Net Debt/FCF—
Balance Sheet
Debt/Equity0.09
Current Ratio3.50
Quick Ratio2.29
Book Value/Sh0.08 USD
Cash/Share0.0041 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.67.73M
Float48.36M
Insiders15.47%
Institutions34.86%
Technical
SMA 500.1839 (-11.9%)
SMA 2000.1804 (-10.3%)
Beta-0.64
S&P 52W Chg12.00%
Avg Vol (30d)51.43K
Avg Vol (10d)48.75K
Technical Indicators
RSI (14)41.4
MACD-0.0587
MACD Signal-0.0627
MACD Hist.+0.0040
BB Upper0.1862 USD
BB Middle0.1712 USD
BB Lower0.1561 USD
BB Width17.57%
ATR (14)0.0146 USD
Vol Ratio (20d)0.13x

About aXichem (STO: AXIC-A)

›

aXichem (STO: AXIC-A) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 7 employees.

The shares were at 1.645 SEK on 19 November 2026, down 36.5% over 52 weeks. Its 52-week range is 1.135 SEK to 4.000 SEK: the price is 58.9% below the high and 44.9% above the low.

Its market capitalisation is 111.41M SEK.

aXichem reports return on equity of -33.4%, an operating margin of -94.2% and revenue down 39.4% year over year.

It holds more cash than debt, a net cash position of 2.28M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.